Amaero shareholders approve all items except withdrawn executive grant
- Stockholders approved all agenda items at the Aug 28, 2026 Special Meeting
- Item 8 regarding CEO Hank Holland’s equity grants was withdrawn by the Company
- All other resolutions were carried by way of a poll
- Detailed proxy results are available in the attached summary

*this image is generated using AI for illustrative purposes only.
Amaero Inc. (ASX:3DA) announced that its stockholders passed all items on the agenda at the 2026 Special Meeting of Stockholders held on August 28, 2026, with one exception.
The Company withdrew Item 8 from consideration after further review. This item concerned the approval of restricted stock units and performance stock units granted to Chairman and CEO Hank J. Holland.
All remaining resolutions were carried by way of a poll. The detailed results, including proxies received for each resolution, are outlined in the attached proxy summary.
Corporate Governance Update
The withdrawal of the executive compensation item indicates a procedural adjustment rather than a rejection by shareholders. The Company stated that the decision to withdraw Item 8 followed an internal review process.
Hank J. Holland authorized the release of this announcement. Amaero continues to operate as a leading U.S. domestic producer of high-value refractory alloy and titanium powders for additive manufacturing in defense, space, aviation, and medical sectors.
What the Numbers Show
The voting results demonstrate unanimous support for the Company’s broader corporate agenda, as every item presented for a poll was approved. The sole deviation was the pre-meeting withdrawal of the specific equity grant proposal for the CEO, removing it from shareholder vote entirely.
Will Amaero Inc. resubmit the withdrawn executive compensation proposal for CEO Hank J. Holland at a future shareholder meeting, and if so, what modifications might be expected?
How does the withdrawal of Item 8 impact investor confidence in Amaero's corporate governance practices compared to peers in the additive manufacturing sector?
Given the unanimous approval of all other agenda items, what specific strategic initiatives or capital allocation plans are likely to be prioritized by the board in the coming fiscal year?



























